Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 25

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 25
---
 prospectus forms a part effective until the earlier of (i) the date on which the Shares may be resold
by the selling stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144,
without the requirement for us to be in compliance with the current public information under Rule 144 under the Securities Act or any
other rule of similar effect, and (ii) all of the Shares have been sold pursuant to this prospectus or Rule 144 under the Securities Act
or any other rule of similar effect. The resale Shares will be sold only through registered or licensed brokers or dealers if required
under applicable state securities laws. In addition, in certain states, the resale Shares covered hereby may not be sold unless they have
been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available
and is complied with.

Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale Shares may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the selling
stockholders or any other person. We will make copies of this prospectus available to the selling stockholders and have informed them
of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule
172 under the Securities Act).

<div align='center'>14

LEGAL MATTERS</div>

The validity of the Common Stock being offered by this prospectus is being passed upon by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., San Diego, California.

<div align='center'>EXPERTS</div>

The consolidated financial
statements incorporated by reference in this prospectus and elsewhere in the registration statement have been so incorporated by reference
in reliance upon the report of Grant Thornton Audit Pty Ltd, independent registered public accountants, upon the authority of said firm
as experts in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We file reports, proxy statements
and other information with the SEC. The SEC maintains a website that contains reports, proxy